Investigational Drug Information for Laninamivir
✉ Email this page to a colleague
What is the development status for investigational drug Laninamivir?
Laninamivir is an investigational drug.
There have been 5 clinical trials for Laninamivir.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2013.
The most common disease conditions in clinical trials are Influenza, Human, Asthma, and [disabled in preview]. The leading clinical trial sponsors are Biota Scientific Management Pty Ltd, Department of Health and Human Services, and National Institute of Allergy and Infectious Diseases (NIAID).
Summary for Laninamivir
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 248 |
| WIPO Patent Applications | 164 |
| Japanese Patent Applications | 69 |
| Clinical Trial Progress | Phase 2 (2013-05-01) |
| Vendors | 38 |
Recent Clinical Trials for Laninamivir
| Title | Sponsor | Phase |
|---|---|---|
| ADaptive ASsessment of TReatments for influenzA: A Phase 2 Platform Trial of Antiviral Pharmacodynamics in Early Symptomatic Influenza | University of Oxford | Phase 2 |
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza | Department of Health and Human Services | Phase 1/Phase 2 |
| Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza | Biota Scientific Management Pty Ltd | Phase 1/Phase 2 |
Clinical Trial Summary for Laninamivir
Top disease conditions for Laninamivir
Top clinical trial sponsors for Laninamivir
US Patents for Laninamivir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
